Thermo Fisher Scientific Inc. has strengthened its bioprocessing capabilities across Asia with the launch and expansion of its Bioprocess Design Center network, reinforcing its strategic commitment to supporting the region’s rapidly growing biopharmaceutical landscape.
The company has opened a new Bioprocess Design Center in Hyderabad, India, while expanding its facilities in Incheon, Korea, and Singapore to meet increasing demand for biologics, vaccines and cell and gene therapies.
Bioprocess Design Center Expansion Strengthens Asia’s Biopharma Growth
The expanded Bioprocess Design Center network enhances Thermo Fisher’s regional infrastructure, providing localized expertise, advanced technologies and customized bioprocessing solutions that accelerate biologics development and manufacturing.
Also Read: AI in Biopharma: ThinkBio Ai and UST Launch Strategic Alliance
Asia continues to emerge as a global biopharmaceutical hub, driven by rising innovation and the need for advanced therapeutic solutions. Thermo Fisher’s investments aim to support this growth by ensuring customers have access to world-class tools, technical support and optimized workflows closer to their operations.
Daniella Cramp, Senior Vice President and President, BioProduction at Thermo Fisher Scientific, stated that the network expansion across Korea, Singapore and India will help customers deliver high-quality biologics more efficiently and sustainably.
Tri-Hub Bioprocess Design Center Network Boosts Regional Innovation
Thermo Fisher’s interconnected Bioprocess Design Centers in Incheon, Hyderabad and Singapore are designed to accelerate process development, advance innovation and strengthen collaboration with biopharma customers throughout Asia.
Incheon, Korea: Expanded Bioprocess Design Center Capabilities
The Incheon facility now offers upgraded laboratory infrastructure, advanced materials and improved collaboration spaces to support deeper engagement and innovation-driven projects.
Hyderabad, India: New Bioprocess Design Center in Genome Valley
The new Hyderabad Bioprocess Design Center, developed in partnership with the Government of Telangana, provides collaborative areas for process design, simulation and optimization.
Customers can co-create and test bioprocesses using state-of-the-art single-use and hybrid systems, contributing to India’s expanding biomanufacturing ecosystem.
Also Read: Nafithromycin: India’s First Home-Grown Antibiotic Marks Breakthrough in Biotech Innovation
Singapore: Scalable Bench-to-Pilot Bioprocessing
The expanded Singapore center enables biopharma innovators to access bench-to-pilot scale capabilities, expert-led training and technical collaborations to accelerate early-stage bioprocess development and support sustainable biomanufacturing.
Collectively, these centers offer customers direct access to innovation, operational agility and advanced support to shorten time-to-market for biological products.
Supporting the Full Biopharma Lifecycle
Thermo Fisher’s end-to-end suite of technologies – ranging from next-generation sequencing and mass spectrometry to advanced bioprocessing systems – continues to empower customers from research to commercialization. The company’s integrated portfolio extends across life sciences, diagnostics, analytical instruments and pharma services.
Tony Acciarito, President for Asia Pacific & Middle East, Africa at Thermo Fisher Scientific, noted that strategic regional investments and collaborations are helping redefine biologics production while strengthening Asia’s biopharma ecosystem.
